Vanguard Capital Management reports 13.7M shares in Organon (OGN)
Rhea-AI Filing Summary
Organon & Co reported that Vanguard Capital Management beneficially owned 13,717,181 shares of Common Stock, representing 5.26% of the class as of 03/31/2026. The filing lists 1,980,163 shares as sole voting power and 13,717,181 shares as sole dispositive power. The disclosure attributes ownership to Vanguard Capital Management LLC and affiliated Vanguard entities.
Positive
- None.
Negative
- None.
Insights
Vanguard reports a >5% stake in Organon, showing institutional scale ownership.
The filing documents 13,717,181 shares (5.26%) beneficially owned as of 03/31/2026, with dispositive authority held by Vanguard Capital Management LLC and named affiliates. This is a standard Schedule 13G disclosure of beneficial ownership by an investment manager.
Actual voting and disposition are concentrated: 1,980,163 shares of sole voting power versus 13,717,181 shares dispositive. Subsequent filings may update holdings; timing and trading intent are not specified in this excerpt.